Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Respir Med. 2016 Nov 4;121:117–122. doi: 10.1016/j.rmed.2016.11.007

Table 2. Reasons for azathioprine and mycophenolate mofetil discontinuation during follow-up period.

Reason Azathioprine (n=54) Mycophenolate mofetil (n=43)
Elevated transaminase 4 0
Pancreatitis 1 0
Nausea/vomiting 1 1
Recurrent infection 1 0
Cytopenia 0 1
Patient Preference 1 5
Disease progression/treatment failure 6 4
Unknown 1 1